Background: The T1D Exchange QI Collaborative (T1DX-QI) is a network of over fifty endocrinology centers improving type 1 diabetes (T1D) care using QI. Participating centers have access to the QI Portal, an EMR-based data platform to chart and benchmark T1D outcomes. It is a valuable tool for population health and supports use of data to inform clinical QI projects. We aim to demonstrate the use of QI science to increase centers’ QI Portal use.

Methods: Users are classified into Tiers based on their cumulative monthly QI Portal log-ins (Tier 1 = one month or never; Tier 2 = 2 or 3 months total; Tier 3 = 4 or more months total). This measure describes regularly (monthly) use. For this analysis, new users (user accounts younger than 3 months) are not included to establish true use.

Results: The QI Portal has achieved consistent user growth through this project. As users transition from Tier 1 to Tier 3, the latter tiers expand as users consistently use the QI Portal, with a 12% increase in more experienced Tiers (Tiers 2 and 3; Figure 1a). Figure 1b depicts a ~48% increase in the percentage of Tier 3 users since the project started in July 2022 and annotates four Plan-Do-Study-Act (PDSA) cycles.

Conclusion: The T1DX-QI portal usage improved through QI science. These efforts support T1DX-QI centers in more routine use of actionable data and outcomes benchmarking for clinical process improvement.


A.Mungmode: None. K.Gandhi: None. O.Ebekozien: Advisory Panel; Medtronic, Research Support; Eli Lilly and Company, Dexcom, Inc. T1dx-qi collaborative: n/a. V.Elisha: None. N.R.Fogel: None. B.L.Kiesow: None. G.O'malley: Research Support; Dexcom, Inc., Abbott Diabetes, Tandem Diabetes Care, Inc., Omnipod, Eli Lilly and Company. M.A.Clements: Consultant; Glooko, Inc., Research Support; Dexcom, Inc., Abbott Diabetes. M.L.Scott: None. J.A.Indyk: None. M.Gallagher: None.


The Leona M. and Harry B. Helmsley Charitable Trust

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at